182 related articles for article (PubMed ID: 26593376)
21. A new era of disease modeling and drug discovery using induced pluripotent stem cells.
Suh W
Arch Pharm Res; 2017 Jan; 40(1):1-12. PubMed ID: 27921262
[TBL] [Abstract][Full Text] [Related]
22. [Induced pluripotent stem cell technology and its application in disease research].
Cai CY; Meng FL; Rao L; Liu YY; Zhao XL
Yi Chuan; 2020 Nov; 42(11):1042-1061. PubMed ID: 33229312
[TBL] [Abstract][Full Text] [Related]
23. Development course and an application strategy for induced pluripotent stem cells in regenerative medicine.
Xu Y; Wang J; Mao R; Tang X; Huang R; Wang R; Lin Y
Curr Stem Cell Res Ther; 2014 May; 9(3):244-53. PubMed ID: 24524789
[TBL] [Abstract][Full Text] [Related]
24. In Vivo Cellular Reprogramming: The Next Generation.
Srivastava D; DeWitt N
Cell; 2016 Sep; 166(6):1386-1396. PubMed ID: 27610565
[TBL] [Abstract][Full Text] [Related]
25. Accelerating progress in induced pluripotent stem cell research for neurological diseases.
Ito D; Okano H; Suzuki N
Ann Neurol; 2012 Aug; 72(2):167-74. PubMed ID: 22926850
[TBL] [Abstract][Full Text] [Related]
26. Advances in cell lineage reprogramming.
Zhou J; Yue W; Pei X
Sci China Life Sci; 2013 Mar; 56(3):228-33. PubMed ID: 23526388
[TBL] [Abstract][Full Text] [Related]
27. Induced pluripotent stem cells: progress and future perspectives in the stem cell world.
Rezanejad H; Matin MM
Cell Reprogram; 2012 Dec; 14(6):459-70. PubMed ID: 23035654
[TBL] [Abstract][Full Text] [Related]
28. Timeline: iPSCs--The First Decade.
Chari S; Mao S
Cell Stem Cell; 2016 Feb; 18(2):294. PubMed ID: 26849306
[TBL] [Abstract][Full Text] [Related]
29. SCNT versus iPSCs: proteins and small molecules in reprogramming.
Han F; Li X; Song D; Jiang S; Xu Q; Zhang Y
Int J Dev Biol; 2015; 59(4-6):179-86. PubMed ID: 26505250
[TBL] [Abstract][Full Text] [Related]
30. Can controlled cellular reprogramming be achieved using microRNAs?
Sun X; Fu X; Han W; Zhao Y; Liu H
Ageing Res Rev; 2010 Oct; 9(4):475-83. PubMed ID: 20601195
[TBL] [Abstract][Full Text] [Related]
31. Induced Pluripotent Stem Cells (iPSCs) in Developmental Toxicology.
Easley CA
Methods Mol Biol; 2019; 1965():19-34. PubMed ID: 31069666
[TBL] [Abstract][Full Text] [Related]
32. Investigating pediatric disorders with induced pluripotent stem cells.
Durbin MD; Cadar AG; Chun YW; Hong CC
Pediatr Res; 2018 Oct; 84(4):499-508. PubMed ID: 30065271
[TBL] [Abstract][Full Text] [Related]
33. Small molecule compound induces chromatin de-condensation and facilitates induced pluripotent stem cell generation.
Wei X; Chen Y; Xu Y; Zhan Y; Zhang R; Wang M; Hua Q; Gu H; Nan F; Xie X
J Mol Cell Biol; 2014 Oct; 6(5):409-20. PubMed ID: 24838272
[TBL] [Abstract][Full Text] [Related]
34. Chemical transdifferentiation: closer to regenerative medicine.
Xu A; Cheng L
Front Med; 2016 Jun; 10(2):152-65. PubMed ID: 27142989
[TBL] [Abstract][Full Text] [Related]
35. Direct cardiac reprogramming: progress and challenges in basic biology and clinical applications.
Sadahiro T; Yamanaka S; Ieda M
Circ Res; 2015 Apr; 116(8):1378-91. PubMed ID: 25858064
[TBL] [Abstract][Full Text] [Related]
36. Advances in the Production and Application of Induced Pluripotent Stem Cells.
Mortada I; Bilani N
Curr Stem Cell Res Ther; 2017; 12(8):637-643. PubMed ID: 28969537
[TBL] [Abstract][Full Text] [Related]
37. Concise Review: Towards the Clinical Translation of Induced Pluripotent Stem Cell-Derived Blood Cells-Ready for Take-Off.
Haake K; Ackermann M; Lachmann N
Stem Cells Transl Med; 2019 Apr; 8(4):332-339. PubMed ID: 30585439
[TBL] [Abstract][Full Text] [Related]
38. Epigenetic reprogramming of cell identity: lessons from development for regenerative medicine.
Basu A; Tiwari VK
Clin Epigenetics; 2021 Jul; 13(1):144. PubMed ID: 34301318
[TBL] [Abstract][Full Text] [Related]
39. Human stem cell research and regenerative medicine--present and future.
Volarevic V; Ljujic B; Stojkovic P; Lukic A; Arsenijevic N; Stojkovic M
Br Med Bull; 2011; 99():155-68. PubMed ID: 21669982
[TBL] [Abstract][Full Text] [Related]
40. Sodium butyrate efficiently converts fully reprogrammed induced pluripotent stem cells from mouse partially reprogrammed cells.
Kang SJ; Park YI; So B; Kang HG
Cell Reprogram; 2014 Oct; 16(5):345-54. PubMed ID: 25093667
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
